These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6175774)

  • 21. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
    Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
    Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
    Hoofnagle JH
    J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitis.
    Guardia J; Esteban R; Buti M; Jardí R; Allende H; Esteban JI
    Liver; 1986 Apr; 6(2):118-22. PubMed ID: 2426552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.
    Hoofnagle JH; Davis GL; Hanson RG; Pappas SC; Peters MG; Avigan MI; Waggoner JG; Howard R; Jones EA; Straus SE
    J Med Virol; 1985 Feb; 15(2):121-8. PubMed ID: 2579192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative use of adenine arabinoside and adenine arabinoside monophosphate in varicella and disseminated zoster in immunosuppressed patients.
    Vilde JL; Bricaire F; Huchon A; Brun-Vezinet F
    J Med Virol; 1983; 12(2):149-53. PubMed ID: 6194253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate.
    Esteban R; Buti M; Vallés M; Allende H; Guardia J
    Hepatology; 1986; 6(4):762-3. PubMed ID: 2426174
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
    Perrillo RP; Regenstein FG; Bodicky CJ; Campbell CR; Sanders GE; Sunwoo YC
    Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.
    Trépo C; Ouzan D; Fontanges T; Chevallier M; Chossegros P; Degos F; Chevallier P; Hantz O
    J Hepatol; 1986; 3 Suppl 2():S97-105. PubMed ID: 2439581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic neuropathy after adenine arabinoside treatment in chronic HBsAg-positive liver disease.
    Kanterewicz E; Bruguera M; Viola C; Lamarca J; Rodés J
    J Clin Gastroenterol; 1990 Feb; 12(1):90-2. PubMed ID: 1689332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection.
    Lok AS; Wilson LA; Thomas HC
    J Antimicrob Chemother; 1984 Jul; 14(1):93-9. PubMed ID: 6207158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of chronic hepatitis B].
    Carreño V; Montaño L; Torres M
    Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of the antiviral effects of adenine arabinoside on chronic HBV infection.
    Watanabe S; Saito S; Yoshikawa A; Shibayama T; Kamimura T; Suzuki S; Ischida F
    Hepatogastroenterology; 1982 Jun; 29(3):102-5. PubMed ID: 7106692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: lack of correlation with DNA polymerase response.
    Liaw YF; Lin DY; Chen TJ; Chu CM; Sheen IS
    Infection; 1984; 12(4):248-50. PubMed ID: 6490167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon therapy for chronic type B hepatitis: the promise comes of age.
    Perrillo RP
    Gastroenterology; 1989 Feb; 96(2 Pt 1):532-5. PubMed ID: 2463207
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
    Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1446-9. PubMed ID: 7680158
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.
    Hafkin B; Pollard RB; Tiku ML; Robinson WS; Merigan TC
    Antimicrob Agents Chemother; 1979 Dec; 16(6):781-7. PubMed ID: 533259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.
    Novick DM; Lok AS; Thomas HC
    J Hepatol; 1985; 1(1):29-35. PubMed ID: 2414358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.
    Chadwick RG; Bassendine MF; Crawford EM; Thomas HC; Sherlock S
    Br Med J; 1978 Aug; 2(6136):531-3. PubMed ID: 698557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of chronic hepatitis caused by hepatitis B virus].
    Ouzan D
    Rev Prat; 1990 May; 40(14):1298-300. PubMed ID: 1694296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.